Recurrent extra skeletal mesenchymal chondrosarcoma of the chest wall. Case report of a rare tumor and a brief review of the literature

Mesenchymal chondrosarcoma (MC) represents only 1% of all chondrosarcomas and, in approximately one-third of cases, is found in extra skeletal sites as extra skeletal mesenchymal chondrosarcoma (EMC). MC can be difficult to diagnose and treat because of its rare and aggressive presentation. We report the case of a 29-year-old female presenting with a gradually enlarging non-tender mass of 8 months duration in the upper part of her left chest wall. She was concerned about breast carcinoma. Imaging studies showed a loosely lobulated, calcified soft tissue mass without an osseous component and not attached to the bone. Core needle biopsy showed a biphasic histomorphology pattern with both undifferentiated small round blue cells and islands of well-differentiated hyaline cartilage. She was diagnosed with EMC, confirmed by molecular testing, which demonstrated a HEY1-NCOA2 gene fusion. The patient was treated by radical surgical excision followed by chemotherapy. Local relapse at the original site was observed 3 years after the remission. She had a repeat wide excision with chest wall reconstruction and subsequently received additional chemotherapy and remained disease-free for three more years until she was lost to follow-up. This report highlights the value of multidisciplinary management of rare, high-grade sarcomas, such as EMC. Long-term survival of EMC is possible with curative-wide surgical excision and individualized adjuvant therapy.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-06-30
DOI
https://doi.org/10.5281/zenodo.17204975
Primary Topic
Phytochemicals and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recurrent extra skeletal mesenchymal chondrosarcoma of the chest wall. Case report of a rare tumor and a brief review of the literature

Zenodo (CERN European Organization for Nuclear Research)
Phytochemicals and Medicinal Plants
article

Recurrent extra skeletal mesenchymal chondrosarcoma of the chest wall. Case report of a rare tumor and a brief review of the literature

article en

Abstract

Mesenchymal chondrosarcoma (MC) represents only 1% of all chondrosarcomas and, in approximately one-third of cases, is found in extra skeletal sites as extra skeletal mesenchymal chondrosarcoma (EMC). MC can be difficult to diagnose and treat because of its rare and aggressive presentation. We report the case of a 29-year-old female presenting with a gradually enlarging non-tender mass of 8 months duration in the upper part of her left chest wall. She was concerned about breast carcinoma. Imaging studies showed a loosely lobulated, calcified soft tissue mass without an osseous component and not attached to the bone. Core needle biopsy showed a biphasic histomorphology pattern with both undifferentiated small round blue cells and islands of well-differentiated hyaline cartilage. She was diagnosed with EMC, confirmed by molecular testing, which demonstrated a HEY1-NCOA2 gene fusion. The patient was treated by radical surgical excision followed by chemotherapy. Local relapse at the original site was observed 3 years after the remission. She had a repeat wide excision with chest wall reconstruction and subsequently received additional chemotherapy and remained disease-free for three more years until she was lost to follow-up. This report highlights the value of multidisciplinary management of rare, high-grade sarcomas, such as EMC. Long-term survival of EMC is possible with curative-wide surgical excision and individualized adjuvant therapy.

Zenodo (CERN European Organization for Nuclear Research)
St. George's University (GD), Saint Vincent's Catholic Medical Center (US), Ross University School of Medicine (BB)
Life below water
Openalex Percentile: Top 34%
Phytochemicals and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Recurrent extra skeletal mesenchymal chondrosarcoma of the chest wall. Case report of a rare tumor and a brief review of the literature · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS